{"id":"https://genegraph.clinicalgenome.org/r/5d456a32-3562-4524-a04e-4b830d8f65a5v1.2","type":"EvidenceStrengthAssertion","dc:description":"NKX2-5 was first reported in relation to autosomal dominant dilated cardiomyopathy (DCM) in 2013 (Costa et al., 2013, PMID: 23661673).  Human genetic evidence supporting this gene-disease relationship includes case-level data. At least 3 variants (all missense) have been reported in humans with DCM (Costa et al., 2013, PMID: 23661673, Hanley et al., 2016, PMID: 27855642 and Sveinbjornsson et al., 2018, PMID: 30354339). In addition, this gene-disease assertion is supported by animal models (Pashmforoush et al., 2004, PMID: 15109497, Kasahara et al., 2001, PMID: 11457872 and Furtado et al., 2017, PMID: 28352650), expression studies (Alimadadi et al., 2020, PMID: 31948008 and McKown et al., 2018, PMID: 30364772) and in vitro functional assays (Costa et al., 2013, PMID: 23661673). NKX2-5 has not been curated by other Gene Curation Expert Panels, but has been asserted with other cardiovascular phenotypes including congenital structural heart disease.  In summary, there is limited evidence to support this gene-disease relationship. More evidence is needed to support the relationship of NKX2-5 with autosomal dominant DCM. This classification was approved by the ClinGen Dilated Cardiomyopathy Working Group on August 28, 2020 (SOP Version 7).","dc:isVersionOf":"https://genegraph.clinicalgenome.org/r/5d456a32-3562-4524-a04e-4b830d8f65a5","GCISnapshot":"https://genegraph.clinicalgenome.org/r/6335de7f-71db-4768-8fa0-6faebd0ea0e8","calculatedEvidenceStrength":"Limited","changes":{"id":"cg:summaryChange"},"contributions":[{"id":"https://genegraph.clinicalgenome.org/r/6335de7f-71db-4768-8fa0-6faebd0ea0e8_publish_contrib","agent":"https://genegraph.clinicalgenome.org/agent/10035","date":"2020-11-13T20:59:18.041Z","role":"Publisher"},{"id":"https://genegraph.clinicalgenome.org/r/6335de7f-71db-4768-8fa0-6faebd0ea0e8_contrib","agent":"https://genegraph.clinicalgenome.org/agent/10035","date":"2020-11-06T17:00:00.000Z","role":"Approver"}],"curationReasonDescription":"","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/6335de7f-71db-4768-8fa0-6faebd0ea0e8_overall_genetic_evidence_line","type":"EvidenceLine","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/6335de7f-71db-4768-8fa0-6faebd0ea0e8_seg_el","type":"EvidenceLine","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/e4513496-8e75-480c-9d30-8eeea7121ee9_proband_segregation","type":"FamilyCosegregation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/30354339","rdfs:label":"Large_icelandic_family","family":{"id":"https://genegraph.clinicalgenome.org/r/e4513496-8e75-480c-9d30-8eeea7121ee9","type":"Family","rdfs:label":"Large_icelandic_family","ethnicity":{"id":"https://genegraph.clinicalgenome.org/r/"},"member":{"id":"https://genegraph.clinicalgenome.org/r/08cca96a-0667-4c05-a3f6-5c132ee5d83c","type":"Proband","dc:source":"https://pubmed.ncbi.nlm.nih.gov/30354339","rdfs:label":"NA","ageType":"https://genegraph.clinicalgenome.org/r/","ageUnit":"https://genegraph.clinicalgenome.org/r/","detectionMethod":"","firstTestingMethod":"Whole genome shotgun sequencing","phenotypeFreeText":"NA","previousTesting":false,"previousTestingDescription":"","sex":"UnknownEthnicity","variant":{"id":"https://genegraph.clinicalgenome.org/r/9009eea3-a2ac-4517-ab59-cd39cef2380b_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/30354339","allele":{"id":"https://genegraph.clinicalgenome.org/r/5305a2d2-2f4a-43d8-a7b9-86a221153d50","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_004387.4(NKX2-5):c.435C>G (p.Phe145Leu)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA132259310"}}}}},"phenotypeFreeText":"","phenotypePositiveAllelePositive":10,"proband":{"id":"https://genegraph.clinicalgenome.org/r/08cca96a-0667-4c05-a3f6-5c132ee5d83c"}},{"id":"https://genegraph.clinicalgenome.org/r/95765f02-2de7-4701-8a1b-0163b11b8c89_proband_segregation","type":"FamilyCosegregation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/23661673","rdfs:label":"Family_NKX2-5_I184M","estimatedLodScore":0.6,"family":{"id":"https://genegraph.clinicalgenome.org/r/95765f02-2de7-4701-8a1b-0163b11b8c89","type":"Family","rdfs:label":"Family_NKX2-5_I184M","ethnicity":{"id":"https://genegraph.clinicalgenome.org/r/"},"member":{"id":"https://genegraph.clinicalgenome.org/r/6a052024-1c56-4b18-ae4a-6bd4943b807c","type":"Proband","dc:source":"https://pubmed.ncbi.nlm.nih.gov/23661673","rdfs:label":"II-4","ageType":"https://genegraph.clinicalgenome.org/r/","ageUnit":"https://genegraph.clinicalgenome.org/r/","detectionMethod":"","previousTesting":false,"previousTestingDescription":"","sex":"Male","variant":{"id":"https://genegraph.clinicalgenome.org/r/cd1a6887-0621-4ac9-b858-24938c55d976_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/23661673","allele":{"id":"https://genegraph.clinicalgenome.org/r/b3b9d7c0-a19f-4563-b63b-14eb3a799816","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_004387.4(NKX2-5):c.552C>G (p.Ile184Met)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA362161630"}}}}},"meetsInclusionCriteria":false,"phenotypeFreeText":"","phenotypePositiveAllelePositive":3,"phenotypes":["obo:HP_0001631","obo:HP_0005110","obo:HP_0001709","obo:HP_0011712"],"proband":{"id":"https://genegraph.clinicalgenome.org/r/6a052024-1c56-4b18-ae4a-6bd4943b807c"}}],"specifiedBy":"GeneValiditySegregationEvidenceCriteria","strengthScore":0},{"id":"https://genegraph.clinicalgenome.org/r/6335de7f-71db-4768-8fa0-6faebd0ea0e8_ad_other_el","type":"EvidenceLine","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/9009eea3-a2ac-4517-ab59-cd39cef2380b_proband_score_evidence_line","type":"EvidenceLine","dc:description":"This is a missense variant without functional evidence. We therefore chose to downgrade the score from 0.5 to 0.1.","calculatedScore":0.5,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/08cca96a-0667-4c05-a3f6-5c132ee5d83c"}],"specifiedBy":"GeneValidityProbandADNonNullCriteria","strengthScore":0.1},{"id":"https://genegraph.clinicalgenome.org/r/cd1a6887-0621-4ac9-b858-24938c55d976_proband_score_evidence_line","type":"EvidenceLine","calculatedScore":0.5,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/6a052024-1c56-4b18-ae4a-6bd4943b807c"}],"specifiedBy":"GeneValidityProbandADNonNullCriteria","strengthScore":0.5},{"id":"https://genegraph.clinicalgenome.org/r/8ae0bd2b-8661-4c2c-a896-f713249c3866_proband_score_evidence_line","type":"EvidenceLine","dc:description":"This is a missense variant without functional evidence","calculatedScore":0.5,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/dc94824c-a3fe-4283-8d2d-da603be9dbca","type":"Proband","dc:source":"https://pubmed.ncbi.nlm.nih.gov/27855642","rdfs:label":"III-5","ageType":"https://genegraph.clinicalgenome.org/r/","ageUnit":"https://genegraph.clinicalgenome.org/r/","detectionMethod":"","firstTestingMethod":"Exome sequencing","previousTesting":false,"previousTestingDescription":"","sex":"Female","variant":{"id":"https://genegraph.clinicalgenome.org/r/8ae0bd2b-8661-4c2c-a896-f713249c3866_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/27855642","allele":{"id":"https://genegraph.clinicalgenome.org/r/1d84b5c8-a16f-4bfa-9b2b-63870ad71966","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_004387.4(NKX2-5):c.550A>T (p.Ile184Phe)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA362161636"}},"alleleOrigin":{"id":"cg:GermlineAlleleOrigin"},"paternityMaternityConfirmed":"No"}}],"specifiedBy":"GeneValidityProbandADNonNullCriteria","strengthScore":0.1},{"id":"https://genegraph.clinicalgenome.org/r/f86e4efe-f0d3-4816-bc59-041065df93c6_proband_score_evidence_line","type":"EvidenceLine","calculatedScore":0.5,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/c0ef9a73-5deb-4bcf-97ed-674e666b1b48","type":"Proband","dc:source":"https://pubmed.ncbi.nlm.nih.gov/27855642","rdfs:label":"III-1","ageType":"https://genegraph.clinicalgenome.org/r/","ageUnit":"https://genegraph.clinicalgenome.org/r/","detectionMethod":"","firstTestingMethod":"Exome sequencing","previousTesting":false,"previousTestingDescription":"","sex":"Female","variant":{"id":"https://genegraph.clinicalgenome.org/r/f86e4efe-f0d3-4816-bc59-041065df93c6_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/27855642","allele":{"id":"https://genegraph.clinicalgenome.org/r/b3b9d7c0-a19f-4563-b63b-14eb3a799816"}}}],"specifiedBy":"GeneValidityProbandADNonNullCriteria","strengthScore":0.5}],"specifiedBy":"GeneValidityOverallAutosomalDominantOtherVariantEvidenceCriteria","strengthScore":1.2}],"specifiedBy":"GeneValidityOverallGeneticEvidenceCriteria","strengthScore":1.2},{"id":"https://genegraph.clinicalgenome.org/r/6335de7f-71db-4768-8fa0-6faebd0ea0e8_experimental_evidence_line","type":"EvidenceLine","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/6335de7f-71db-4768-8fa0-6faebd0ea0e8_functional_evidence_line","type":"EvidenceLine","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/b943c186-2a4c-4936-8094-615908f1674c","type":"EvidenceLine","calculatedScore":0.5,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/d9a00c57-11c6-4a54-9dca-fe9081753595","type":"Finding","dc:description":"NKX2-5 was among the top 50 differentially expressed genes in DCM vs. controls\nNKX2-5 was downregulated in DCM heart vs. controls","dc:source":"https://pubmed.ncbi.nlm.nih.gov/31948008","rdfs:label":"RNA-seq meta-analysis of 41 DCM vs 21 controls","demonstrates":{"id":"cg:GeneExpressionB"}}],"specifiedBy":"GeneValidityGeneExpressionCriteria","strengthScore":0.5}],"specifiedBy":"GeneValidityOverallFunctionalEvidenceCriteria","strengthScore":0.5},{"id":"https://genegraph.clinicalgenome.org/r/6335de7f-71db-4768-8fa0-6faebd0ea0e8_model_rescue_evidence_line","type":"EvidenceLine","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/759ff71e-9258-48dc-bf11-b45c1a85acb6","type":"EvidenceLine","dc:description":"The mice studied were homozygous whereas the human patients were found to have heterozygous variants in NKX2-5. We therefore chose to downgrade the default score from 2 to 1.","calculatedScore":2,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/73af9a9e-16ce-4d67-ad54-30a07f209dbb","type":"Finding","dc:description":"The muscle cell-restricted knockout KO mice displayed marked cardiac enlargement and progression to heart failure with concomitant dilatation of bother chamber, mirroring the dilated cardiomyopathy observed in human.","dc:source":"https://pubmed.ncbi.nlm.nih.gov/15109497","rdfs:label":"KO mice","demonstrates":{"id":"cg:ProteinAlterationDisruptsOrganismFunction"}}],"specifiedBy":"GeneValidityNonHumanModelOrganismCriteria","strengthScore":1},{"id":"https://genegraph.clinicalgenome.org/r/d1b904ac-fc90-43e5-971a-25e1fa25b490","type":"EvidenceLine","dc:description":"While the ventricular dilatation and reduction of left ventricular function are shared characteristics of human dilated cardiomyopathy, the effects one ventricular function were mild and not consistent across other mutant line. We therefore chose to downgrade the default score of 2 to 1.","calculatedScore":2,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/48356a19-40f3-45f2-952a-e6538d57c85b","type":"Finding","dc:description":"The ventricular dilatation and reduction of left ventricular function are shared characteristics of human dilated cardiomyopathy. \n\nThe heterozygous mice displayed (1) right ventricle and right atrial dilation, (2) increased trabecular layers on the left ventricular wall, indicative of left ventricular noncompaction (3) right ventricular dysfunction in both mutant lines, associated with a significant decrease in right ventricle ejection fraction (4) left ventricular function was only affected in Nkx2-5183M/+ mice, which showed decreased end diastolic volume (LV-EDV) and stroke volume (LV-SV) and heart mass (LV-mass)","dc:source":"https://pubmed.ncbi.nlm.nih.gov/28352650","rdfs:label":"Heterozygous Nkx2-5 mice","demonstrates":{"id":"cg:ProteinAlterationDisruptsOrganismFunction"}}],"specifiedBy":"GeneValidityNonHumanModelOrganismCriteria","strengthScore":1},{"id":"https://genegraph.clinicalgenome.org/r/7803f646-0b97-4cac-ab4f-5496f8ed8e3b","type":"EvidenceLine","dc:description":"The mice studied were overexpressing the NKX2-5 allele with p.I183P, whereas the human patients were found to have heterozygous variants in NKX2-5. We therefore chose to downgrade the default score from 2 to 1.","calculatedScore":2,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/9f0d4941-b1c2-4f58-b769-61e62f94a1d6","type":"Finding","dc:description":"Overexpression of the NKX2-5 allele with p.I183P in mice results in progressive cardiac conduction disease and heart failure, with severe ventricular dilatation, mirroring the dilated cardiomyopathy observed in human.","dc:source":"https://pubmed.ncbi.nlm.nih.gov/11457872","rdfs:label":"Transgenic mice","demonstrates":{"id":"cg:ProteinAlterationDisruptsOrganismFunction"}}],"specifiedBy":"GeneValidityNonHumanModelOrganismCriteria","strengthScore":1}],"specifiedBy":"GeneValidityOverallModelAndRescueEvidenceCriteria","strengthScore":3}],"specifiedBy":"GeneValidityOverallExperimentalEvidenceCriteria","strengthScore":3.5}],"evidenceStrength":"Limited","sequence":1485,"specifiedBy":"GeneValidityCriteria7","strengthScore":4.7,"subject":{"id":"https://genegraph.clinicalgenome.org/r/6pg3vTV52KI","type":"GeneValidityProposition","disease":"obo:MONDO_0005021","gene":"hgnc:2488","modeOfInheritance":"obo:HP_0000006"},"version":"1.2","websiteLegacyID":"https://genegraph.clinicalgenome.org/r/assertion_6335de7f-71db-4768-8fa0-6faebd0ea0e8-","@context":{"@vocab":"https://genegraph.clinicalgenome.org/terms/","id":"@id","type":"@type","cg":"https://genegraph.clinicalgenome.org/terms/","dc":"http://purl.org/dc/terms/","obo":"http://purl.obolibrary.org/obo/","hgnc":"https://identifiers.org/hgnc:","rdfs":"http://www.w3.org/2000/01/rdf-schema#","cggv":"https://genegraph.clinicalgenome.org/r/gci/","evidenceStrength":{"@type":"@vocab"},"calculatedEvidenceStrength":{"@type":"@vocab"},"computedEvidenceStrength":{"@type":"@vocab"},"specifiedBy":{"@type":"@vocab"},"evidence":{"@container":"@set"},"disease":{"@type":"@vocab"},"gene":{"@type":"@vocab"},"phenotypes":{"@type":"@id"},"agent":{"@type":"@id"},"role":{"@type":"@vocab"},"modeOfInheritance":{"@type":"@vocab"},"sex":{"@type":"@vocab"},"direction":{"@type":"@vocab"},"ageType":{"@type":"@vocab"},"ageUnit":{"@type":"@vocab"},"dc:source":{"@type":"@id"},"curationReasons":{"@type":"@vocab","@container":"@set"},"GCISnapshot":{"@type":"@id"},"dc:isVersionOf":{"@type":"@id"},"websiteLegacyID":{"@type":"@id"}}}